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Прематурната ретинопатија  (РОП) е главна причина за слепило кај предвремено родените бе-
биња. Инциденцата на РОП се зголемува во земјите во развој  и се должи на зголемување на пре-
живување на предвремено родените деца. Прематурната ретинопaтија (РОП) е сериозна компли-
кација кај предвремено родени деца која може да доведе до слепило, освен ако се дијагностицира 
и се третира рано. Цел на оваа студија е да се проучат  мајчините и акушерските фактори на ризик 
за РОП. Материјал и методи: Истражувањето преставува аналитичка  “Case control” студија во 
периодот 2015-2016г. Во студијата се вклучени  163 предвреме родени деца кои не ги исполнуваат 
критериумите на Американската академија за офталмологија (ААО), со родилна тежина се  над 
1500 г и гестациска старост над 30 недела. Мајките се поделени во две групи во однос на новороде-
ните со РОП и без. За оставрување на целите се користеше дводелен анкетен прашалник, првиот 
дел од прашалникот се однесува на прашања за мајката. Резултати: ИВФ (ин витро фертилизациа) 
ја зголемува веројатноста за РОП повеќе од два пати OR=2.1256 (1.1133-4.0585). Како независни фак-
тори  мултипната бременост ја зголемува веројатноста за РОП за два и пол пати. Прееклампсијата 
делува протективно, ја намалува веројатноста за настанување на РОП. Начинот на породување, 
возраста на мајката, број на бремености, број на раѓања, консумирање на алкохол, пушење, нарко-
тици не претставувaат ризик фактори. Треба да се обрне големо внимание на дефинирањето на 
ризик факторите, нивната комплексност, развојот и прогресијата на прематурната ретинопатија 
и нејзината превенција  кои се само еден дел од прашањата со кој се соочуваат офталмолозите и 
неонатолозитe во текот на  својата работа. Во студијата се потврдија истите ризик факори кои се 
регистрираат на кај прематурусите според ААО (родилна тежина под 1500 г и под 30-та гестациска 
недела). Заклучок: протоколите за скрининг на РОП да се модифицираат, покрај инклузионите 
критериуми на ААО да се вклучат и прематуруси според препораката на неонатолозите за зголе-
мен ризик за развој на прематурна ретинопатија, а се со родилна тежина над 1500 г и над 30-та 
гестациска недела.
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Retinopathy of Prematurity (ROP) is a major cause of preventable blindness in preterm infants. 
The incidence of ROP is increasing in developing countries due to increased survival of preterm 
infants. Retinopathy of prematurity (ROP) is a serious complication of prematurity and can lead 
to blindness unless is recognized and treated early. The aim of our study was to study maternal 
and obstetric risk factors for ROP. Material and methods: The research was an analytical „Case 
control“ study in the period 2015-2016. The study included 163 premature babies that not meet 
the criteria of the American Academy of Ophthalmology (AAO), with BW more than 1500 g and 
gestational age more than 30 GW. Mothers were divided into two groups according the newborns 
with ROP and without. In order to achieve the goals, a two-part survey questionnaire was used, the 
first part of the questionnaire refers to questions for the mother.  Results: In Vitro Fertilization 
increases the chance of ROP two times OR=2.1256 (1.1133-4.0585). As independent factors, multiple 
pregnancies increase the chance of ROP for fourth times OR = 4.0721 (2.3899-9.2511). Preeclampsia 
acts protective, reduces the chance of occurrence of ROP OR = 0.2147 (0.0706-0.6526). The way of 
delivery, the number of pregnancies, number of births, alcohol consumption, smoking, narcotics, 
did not present as risk factors. Conclusions: We should pay attention to the definition of risk 
factors, their complexity, the development and progression of retinopathy prematurnata and its 
prevention, because they are just one of the issues facing ophthalmologists and neonatologists 
throughout his work. The study confirmed the same risk factors that are registered on neonatal 
premathuruses according to AАО (birth weight below 1500 g and under the 30th gestation week). 
Conclusion: Based on the analysis of the study, a conclusion and recommendation protocols 
criteria to screen for ROP to modify, despite inclusion criteria of AAО to include premature 
neonates in screening for ROP according to the recommendation of neonatologists to increased 
risk of premature retinopathy, with birth weight over 1500 g and over 30 gestation weeks.
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Introduction 
Premature retinopathy or Retinopathy 
of prematurity-ROP is a disease that oc-
curs in premature babies and involves 
the blood vessels of the retina of the eye 
during development. This results in the 
development of vascular shunts, with 
neovascularization and in more severe 
forms, with traction ablation of retina. 
The development of retinal vascular 
shunts and neovascularization in ROP 
are believed to be related to local isch-
emia, which is a dominant feature of 
other proliferative retinopathies such as 
sickle-cell retinopathy and diabetic reti-
nopathy. The only specificity of ROP re-
fers to its occurrence only in premature 
infants with an immature and incom-
plete vascularized retina 1-4.
In premature babies, normal develop-
ment of retinal blood vessels can be 
interrupted, so that the peripherally 
placed parts during their development 
remain without vascularization. Isch-
emia that stimulates neovascular prolif-
eration occurs in peripheral parts of the 
retina. The development of vitreoretinal 
proliferation and traction ablation of the 
retina on this surface causes permanent 
loss of eye function1-3,5.
There are numerous risk factors respon-
sible for the development of premature 
retinopathy that obstruct the normal de-
velopment of retinal vascularity, among 
which maternal and obstetric risk fac-
tors and many others that combine and 
complement each other. 
This eye condition tends to occur only in 
premature babies. It usually affects both 
eyes and is the leading cause of vision 
loss in children. Out of the 28,000 U.S. 
babies born weighting less than 1500g as 
many as 16,000 will develop some form 
of ROP. Fortunately, most of these 90% 
have a mild case and won‘t need treat-
ment. More severe forms of ROP can 
cause vision loss and even blindness if 
not treated1-3,6.
Other risk factors that could contribute 
to the ROP over the years, surprisingly, 
research has lead to findings that pre-ec-
lampsi in the mother can lead to a more 
favorable outcome for newborns, the re-
searchers explain it that stress causes 
hypertension and intrauterine late mat-
uration of eye1-3,8-10. The research of in vi-
tro fertilization as a risk factor is contra-
dictory. Friling et al found no significant 
differences in the incidence and severity 
of ROP between IVF and natural concep-
tion, such as Chinese and Korean studies 
12,13. Watts P. and Adams GGW register 
that IVF- children with ROP had lower 
gestational age and birth weight than 
those IVF babies who have not developed 
ROP. IVF according to them is a risk fac-
tor for the development of ROP. They 
in their research register that 41.6% of 
IVF babies progress to stage 3 ROP com-
pared with only 9.3% of naturally con-
ceived children14. Conceiving with IVF, 
unlike other techniques is a major risk 
factor for the development of ROP. The 
authors advise to increased vigilance in 
screening babies conceived by IVF meth-
od.1-3,15-16. McKibbin and Dabbs after treat-
ment with IVF, 20% of babies were fulfill-
ing screening criteria for ROP 17.
Mother‘s smoking has been identified 
as an important risk factor for ROP18 
In 2006, suggest that elevated mother‘s 
glucose can also play a role in the risk 
factor19-21. 
The aim of the study was to identify 
and analyse maternal and obstetric risk 
factors for retinopathy of prematurity 
in prematures whose weight was over 
1500g and gestational week above 30.
Materials and methods 
The research was an analytical „case 
control“ study (retrospective with pro-
spective approach) in the period 2015-
2016. The study included 163 premature 
babies that did not fulfills criteria ac-
cording the American Academy of Oph-
thalmology (AAA) (birth weight <= 1500 
g and gestational age <= 30 weeks). They 
were examined outside the AAO proto-
col, and in cooperation with neonatolo-
gists. Тhey are involved because of a rec-
ommendation of neonatologists because 
of the possibility to develop ROP. They 
were prematuruses whose birth weight 
were above 1500gr and gestational age 
over 30 weeks In order to achieve the 
objectives used two-part questionnaire 
designed specifically suited for this pur-
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pose and clinical examination. 
The group was divided into premature 
with ROP and without ROP.
The first part of the questionnaire refers 
to questions about the mother, and the 
second part is filled in by the doctor. First 
part: Method of fertilization / natural 
pathway and in vitro fertilization, type 
of pregnancy (one child, twins, triplets), 
number of pregnancies and births, mul-
tiple prenatal maternal factors - smok-
ing, alcohol, drugs, diabetes, preeclamp-
sia, the age of the mother, the method of 
deliver.
Inclusion criteria of prematuruses in 
screening for early detection of ROP: 
birth weight (BW) which was over 1500 
gr. and Gestational age (GW) which was 
over 30 .Exclusive criteria: Infants with 
ocular congenital anomalies, such as 
cataracts, microphthalmia, anophthal-
mia, and coloboma in one or both eyes or 
systemic anomalies.
The Data were analyzed with Statistical 
Package for the Social Sciences (SPSS 
for windows, version 17.0). Descriptive 
statistics include mean and standard 
deviation for numerical variables, and 
percentage of different categories of cat-
egorical variables. Comparison of groups 
was done by chi-square (Χ²) test and 
t-test. Odd ratio was constructed of the 
risk factors that were significant. For CI 
(confidence interval ± 95% CI) is defined 
statistical significance level of error of 
less than 0,05 (p) The results are present-
ed in tables and graphics.
Results
The study included 163 premature ba-
bies, of which 63(38.7%) were with ROP 
and 100(61.3%) were without ROP.
In the group of preterm infants, IVF was 
registered in 63 mothers, and natural re-
production in 100 mothers. In the group 
of mothers with IVF, in preterm infants, 
ROP was found in 47.1%, %, and in 52.9% 
not. In the group of mothers with natu-
ral fertility, in preterm infants ROP was 
registered at 29.5% , and not at 70.7%.The 
percentage difference between preterm 
infants with ROP of was statistically sig-
nificant for p <0.05 (p=0.0212, Difference 
test). A statistically significant associa-
tion between the fertilization method 
and the registration of ROP for p <0.05 
(Pearson Chi-square: 5.2965,  p=.021368) 
was recorded. According Odds ratio IVF 
increases the chance for ROP was two 
OR=2.1256(1.1133-4.0585).
According the delivery, in the group 
of mothers with caesarea section, in 
preterm infants, ROP was found in 40.6%, 
and in 59.4% not. In the group of moth-
ers with vaginal delivery, in preterm in-
fants ROP were registered at 35.4%, and 
not at 64.6%. There was no statistically 
significant association between the way 
of delivery and registration of ROP for 
p> 0.05 (Pearson Chi-square: 0.4231, p = 
0.515398).
Multiple pregnancies in a greater per-
centage of 63.5% were registered in the 
ROP group, and in the group without 
ROP it was registered with 27.0%, the per-
centage difference was statistically sig-
nificant for p <0.05(p=0.000). There was 
statistically significant association be-
tween the multiple pregnancies and reg-
istration of ROP for p< 0.05 (Pearson Chi-
square: 21.2608, p = 0.00008). According 
to the Odds-ratio, multiple pregnancies 
increase the chance for ROP four times 
OR = 4.0721 (2.3899-9.2511)
In both groups a statistically significant 
greater percentage mothers did not 
smoke (90.5%, 90.0%). There was no sta-
tistically significant association between 
the smoking and registration of ROP for 
p> 0.05 (Pearson Chi-square: 0.0099, p = 
0. 920740).
In the group with ROP, mothers do not 
consume alcohol 96.9% and consume 
3.1%. In the group without ROP, moth-
ers do not consume alcohol 98.4%, and 
consume 1.6% There was no statistical-
ly significant association between alco-
hol consumption and the manifestation 
of ROP for p> 0.05 (Pearson Chi-square: 
.07567, p = .384372).
In the group with ROP, mothers did not 
take narcotic substances 84.1% and took 
15.9%. In the group without ROP moth-
ers did not take narcotic substances 
88.0% and took 12.0%. There was no sta-
tistically significant association between 
maternal use of narcotic substances and 
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N=163 %
with ROP 63 38.7
without ROP 100 61.3
way of fertilization IVF(N/%) natural fertilization(N/%)
with ROP 40/47.1 23/29.5
without ROP 45/52.9 55/70.5
way of delivery Caesarean section(N/%) Vaginal delivery (N/%)
with ROP 41/40.6 22/35.5
without ROP 60/59.4 60/64.5
 pregnancy         single(N/%)  twin(N/%) triplets(N/%)
               with ROP                 23/37.5 37/58.7  3/4.8
               without ROP            73/73.0 29/29.0 1/1.0
smoking yes  N/% no   N/% 
with ROP 6/9.5 57/90.5
without ROP 10/ 10.0 90/90.0
alcohol yes  N/% no   N/%        
with ROP 1/ 1.6 62/98.4
without ROP 4/  4.0 96/96.0
narcotic substances yes  N/% no   N/% 
with ROP 10/ 15.9 53/84.1
without ROP 12/ 12.0 88/88.0
pre-eclampsia yes  N/% no   N/% 
with ROP 4/ 6.3 59/92.1
without ROP 24/ 24.0 76/76.0
diabetes mellitus yes  N/% no   N/%        
with ROP 1/ 1.6 62/98.4
without ROP 100/100.0
the manifestation of ROP for p> 0.05 
(Pearson Chi-square: 0.4966, p = .481008).
In the group with ROP, pre-eclampsia 
was not manifested in 93.6% and was 
manifested at 6.4%. In the group without 
ROP, pre-eclampsia was not manifest-
ed in 76.0% and was manifested at 24%. 
There was statistically significant asso-
ciation between the pre-eclampsia and 
registration of ROP for p< 0.05 (Pearson 
Chi-square: 8.4638, p = 0.003622). Ac-
cording to the Odds-ratio, pre-eclampsia 
was not a risk factor, it acts protective 
(reduces the chance) for ROP, OR = 0.2147 
(0.0706-0.6526)
One mother with diabetes was registered 
in the group with ROP (table 1).
Table No 1
Discussion  
Retinopathy is the most important cause 
of blindness in children, which in many 
cases can be prevented. Although great 
progress has been made in the diagno-
sis and treatment of ROP, it is one of 
the major diseases causing blindness in 
children ROP is a multifactorial disease, 
involves many risk factors. The defini-
tion of risk factors, their complexity, the 
development and progression of prema-
ture retinopathy and its prevention are 
just some of the issues facing ophthal-
mologists and neonatologists22.
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Assessment of IVF in the occurrence of 
premature retinopathy is debatable, i.e. 
different authors have come up with 
different conclusions. Berg et al.23 have 
come to the conclusion that IVF is close-
ly related to the emergence of ROP in 
premature babies. In contrast, Friling et 
al.24 did not find significant differences 
in the occurrence and severity of pre-
mature retinopathy between the natural 
conception and IVF. Watts and Adams25 
come to the conclusion in their study 
that IFV more often than other artificial 
insemination techniques were a major 
risk factor for developing a severe form 
of ROP. In our study we came to the con-
clusion that IVF increases the chance for 
ROP more than two and a half times.
ROP occurs in a greater percentage in 
multiple pregnancies in relation to sin-
gle pregnancy in mothers, multiple preg-
nancy increases the chance of ROP for tri 
times. Blumenfeld et al.26 in a large series 
reported that there was no difference in 
the incidence or severity of ROP between 
single or multiple pregnancies. The an-
tenatal risk factors analysis in Kumar‘s 
study showed that multiple pregnancies 
were significant in the ROP group (p = 
0.00)27.
In the study of Seiberth and Lindark-
omp,28 were registered insignificant re-
lationship between the mode of deliv-
ery and the occurrence of ROP. But it is 
in disagreement with Shah et al.29 who 
found that cesarean section was signifi-
cantly associated with the occurrence of 
ROP. No significant relationship has been 
gained between the mode of delivery 
(caesarean section and spontaneously) 
and the occurrence of ROP in our study.
The study did not obtain a link between 
the number of births and the registra-
tion of premature retinopathy.
Babic GS 30, concluded in her study that 
smoking before pregnancy, during preg-
nancy, how many cigarettes are smoked 
per day, the level of mother‘s education 
and the socioeconomic factors were risk 
factors for the occurrence of ROP.
However, smoking of the mother was not 
recommended due to the large number of 
systemic side effects that can cause the 
mother and the newborn. In our study 
neither confirmed nor denied smoking 
that was a risk factor for the occurrence 
of ROP and was not denied and did not 
confirm that it acts protective for the oc-
currence of premature retinopathy. We 
obtained these results on the basis of the 
small number of mothers who smoke in 
the group.
There was no statistically significant link 
between alcohol consumption and ROP 
manifestation in the group. There was 
also no significant link between the con-
sumption of narcotic substances and the 
manifestation of ROP in both groups. In 
contrast to our obtained results, Babić 
30 came to the opposite conclusion that 
the consumption of alcohol and narcotic 
substances is a risk factor for the occur-
rence of ROP.
However, very few studies have been 
published on the relationship between 
preeclampsia and ROP, and they are con-
tradictory22, 30-33. Filho et al. in their study 
concluded that preeclampsia reduces 
the risk of ROP by 60% and is a protec-
tive factor31. Seibrth came to the same 
conclusions in his research28. The find-
ings of Filho and Seibrth were similar to 
ours. In our study, preeclampsia was not 
a risk factor, but rather acts as a protec-
tive factor, reduced the chance of ROP 
occurring. Studies in Turkey have found 
that preeclampsia was a risk factor pre-
cisely, and Gebesce et al.34 study find that 
the odds ratio = OR for maternal pre-
eclampsia with the univariate logistic 
regression was OR=3.2 (1.002-11.535), and 
was confirmed by the Özkan study and 
colleagues35.
Tunay et al. in their research found that 
diabetes in the mother was a risk factor 
for the occurrence of ROP 36 the moth-
er‘s diabetes was registered as an inde-
pendent risk factor for ROP -OR = 25,040 
(12,728-49,264,311). In our research, 4 
cases of mothers of diabetics were reg-
istered.
Conclusions
• In vitro fertilization, multiple preg-
nancies were risk factors and increase 
the chance of premature retinopathy 
occurring.
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• Preeclampsia was not a risk factor 
for ROP, but it has a protective effect
• In the study the next factors were not 
risk factors for the occurrence of pre-
mature retinopathy: the method of 
delivery (caesarean section and spon-
taneous), number of pregnancies, 
number of births, alcohol, smoking 
and narcotics.
The study confirmed the same risk fac-
tors that are registered on neonatal pre-
maturus according to AАО (birth weight 
below 1500 g and under the 30th gesta-
tion week). Based on the analysis of the 
study, a conclusion and recommendation 
are that protocols criteria to screening 
for ROP have to modify, despite inclusion 
criteria of AAО to include prematurus in 
screening for ROP according to the rec-
ommendation of neonatologists which 
increased risk of premature retinopathy, 
with birth weight over 1500 g and over 30 
gestation weeks
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